1910 Genetics is a Series A stage biotechnology company that is pioneering a novel Input-Transform-Output (ITO) platform as the first ever horizontal AI infrastructure for drug discovery.
In a crowded space with hundreds of AI drug discovery companies, 1910's ITO platform is differentiated by:
Modality agnostic drug discovery: our platform is capable of designing both small molecule and large molecule therapeutics across all disease areas, with an initial focus on neuroscience, oncology, and autoimmune diseases.Proprietary massive multimodal data, which overcomes the data scarcity problem that prevents frontier AI models from being utilized for drug discovery.Multi-AI agent systems that include a robust collection of frontier AI/ML models, each of which works in a task-oriented manner to achieve the multi-parameter optimization problem of drug discovery and development.A state-of-the-art (SOTA) fully-automated, high throughput wet laboratory in the premier Boston Seaport District for both data generation for AI model training as well as validation of the safety and efficacy of drug candidates that are outputted by our frontier AI models.An unprecedented partnership with Microsoft, which positions 1910 as the only biotech/pharma company leveraging Azure Quantum Elements, a groundbreaking, AI-driven, high performance computing (HPC) cloud architecture for advanced AI.Bespoke conversational AI chatbots that provide a customer friendly UI/UX to access our platform for specific drug discovery tasks.Being the only biotech company helping pharma companies integrate 6 core areas of AI infrastructure.Role Description Work closely with the senior leadership team (SLT) to develop, implement, and execute a business development strategy that capitalizes on the company's proprietary AI-driven drug design technology platform and internal pipeline of drug candidates.Build, track, and maintain a strong business development funnel of opportunities.Create compelling strategic and commercial justifications of recommended deals including detailed financial models and competitive analyses, formulate and execute negotiations strategy, and with legal advisors, structure, and execute transactions.Design and execute deals around the company's AI-driven drug design technology platform for the design of both small molecule drugs and protein therapeutics for all therapeutic areas including but not limited to neuroscience, infectious disease, autoimmune/immunology, oncology, aging, metabolism, etc.Monetize drugs designed by the platform, leveraging the platform itself as a value driver, crafting the company's strategic positioning, and identifying both organic and inorganic opportunities for growth.Attract joint venture, co-development, collaborative research, strategic corporate investment, equity financing, and non-dilutive financing from pharmaceutical/biotechnology companies, foundations, and government agencies.Diversify the business model, and establish 1910 as a company that derives value from both its internal pipeline and industry-leading AI-driven drug design platform, which serves as the engine for continued growth.Identify, assess, and execute complex, creative deals with a variety of potential partners including pharmaceutical companies, biotech companies, foundations, research institutes, government agencies, etc. These collaborations can take a variety of forms, and include sell-side (and occasionally, buy-side) transactions, as well as joint ventures.The successful candidate must be able to understand these opportunities from a strategic perspective as well as help bring them to fruition through term sheet negotiations and deal execution, working in partnership with the SLT.Qualifications PhD or MD from a top institution; demonstration of a strong scientific background and publication history.MBA, in addition to a PhD or MD is a strong plus.Passion for AI-driven drug discovery and development.5+ years of sell-side business development experience in science-driven biotechnology companies.A robust deal sheet that demonstrates a track record of identifying, evaluating, structuring, negotiating, and executing sell-side deals with biotech and pharma companies.Owing to the extensive and impressive deal sheet, has credibility within the biotech and pharmaceutical industry as a science-driven business leader of high intellect and character.Diversity and Inclusion (1910's Promise) At 1910, we believe that a diverse, equitable, and inclusive workplace furthers relevance, resilience, and longevity. We encourage people from all backgrounds, ages, abilities, and experiences to apply. 1910 is proud to be an equal-opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity, or Veteran status. If, due to a disability, you need an accommodation during any part of the interview process, please let your recruiter know. While 1910 supports visa sponsorship, sponsorship opportunities may be limited to certain roles and skills.
#J-18808-Ljbffr